Start a Phase 1b/Phase 2 study of ACE-1334 in patients with SSc-ILD
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- October 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Acceleron expects to start a Phase 1b/Phase 2 study to evaluate the activity of ACE-1334 in patients with SSc-ILD in 2021.”
What we found
Evidence strength A What the grades mean
A November 2021 10-Q and 8-K report that Acceleron initiated the ACE-1334 Phase 1b/Phase 2 SSc-ILD trial in October 2021, before the year-end 2021 deadline.
-
A Acceleron Pharma Inc. 8-K filed 2021-11-04
“In October, Acceleron initiated a Phase 1b study to evaluate the activity of ACE-1334 in patients with SSc-ILD.” ✓ confirmed on the page
-
A Acceleron Pharma Inc. 10-Q filed 2021-11-04
“We initiated a Phase 1b/Phase 2 clinical trial with ACE-1334 in patients with SSc-ILD in October 2021.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Start
- Deliverable
- Phase 1b/Phase 2 study of ACE-1334 in SSc-ILD
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Acceleron Pharma Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C280600-024525 · Corrections policy